Anzeige
Mehr »
Login
Samstag, 19.04.2025 Börsentäglich über 12.000 News von 690 internationalen Medien
Trumps Dekret beschleunigt Antimon-Boom - Wird Global Tactical der nächste Highflyer für kritische Mineralien?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Zacks

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiNutanix Dips 12% in a Month: Should You Hold or Fold the Stock?
MiReasons to Add American Water Works to Your Portfolio Right Now
MiNSC Set to Report Q1 Earnings: What's in the Offing for the Stock?
MiShould You Buy The New York Times Stock at Its Discounted Price?
Mi3 Stocks Flashing Bullish Momentum
MiSolid Leverage Loan Issuance to Support Moody's Q1 Earnings
MiAECOM Secures Major Infrastructure Contracts in Hong Kong With JV
MiCBLL Stock Falls Despite FDA Clearance for Pediatric Clarity Algorithm
MiZillow Launches New Listing Performance Insights for Showcase Listings
MiOllie's Bargain Stock Up 11% in a Month: Lock in Gains or Hold?
MiHWC Q1 Earnings Beat Estimates on NII & Fee Income Growth
MiPilgrim's Pride Looks Undervalued: Is Now the Time to Buy PPC Stock?
MiIBM vs. Microsoft: Which Cloud Computing Stock is a Better Bet?
MiCYH to Sell Stake in Cedar Park Regional to Ascension in $460M Deal
MiIs it the Right Time to Hold STERIS Stock in Your Portfolio?
MiLabcorp Q1 Earnings Preview: Diagnostics Arm Likely to Drive Growth
MiHere's Why You Must Add DRS Stock to Your Portfolio Right Now
MiJAKKS Pacific's Disguise Secures New Sonic Licensing Agreement
MiTELUS to Set Up Sovereign AI Factories in Kamloops & Rimouski
MiGilat Wins Multimillion Defense Deal for Antenna Technology
MiReasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now
MiVolatile Markets? Try These Relative Price Strength Stocks
MiHere's Why Investors Should Retain Bragg Gaming Stock for Now
MiO'Reilly Gears Up to Report Q1 Earnings: Here's What to Expect
MiDTIL Gets FDA's Fast Track Tag for Hepatitis B Gene Therapy, Stock Up